Research On Light Assets Operation Mode And Performance Evaluation Of Pharmaceutical Enterprises

With the rapid development of Internet technology and capital market,an enterprise must abandon the invariable business model if it wants to keep vigorous vitality in the long stream of time from birth to growth different models of development strategies should be developed according to different stages.According to the current market environment,enterprises want to maximize value,not only rely on strong profitability and market share,but should comply with the current trend of development toward the "No Man can have what I have,I'm better at what I do,I seek change when others do well" direction to develop.This "change" is innovation,that is,R & D capacity,sales capacity and supply chain production capacity of the focus.Under this background,"light asset operation mode" emerges as the Times require.In recent years,China's innovative pharmaceutical enterprises,represented by Jiangsu Hengrui Medicine Co.,Ltd.(hereinafter referred to as "Hengrui medicine"),have developed rapidly In 2006,Hengrui began to change its production and corporate management strategy and adopt the light asset operation mode? Under this mode,how does the performance of Hengrui pharmaceutical company be affected?Based on the above-mentioned problems,this paper first gives a systematic exposition of the background and significance of the topic selection The paper puts forward two questions: The motivation of light assets operation mode and the impact of light assets operation mode on the performance of pharmaceutical enterprises.Secondly,through the use of domestic and foreign scholars theory and case discussion of the combination of research conclusions on the implementation of light assets mode of operation and performance evaluation are outlined And in the relevant theoretical basis and industry policy analysis of the background to re-interpretation of the model.Then it analyzes the status quo of the implementation of the light-asset Operation Model in China's Pharmaceutical Industry Through the comparative analysis of the financial data of four pharmaceutical companies listed on the a stock market,the light assets operation mode is used to evaluate the financial performance and non-financial performance of the pharmaceutical industry.Then,through the analysis of the basic situation,the general operating situation and the financial and non-financial indicators of hengrui pharmaceutical company in the past five years,it is concluded that the light assets operation mode forms the evaluation of the performance of Pharmaceutical Enterprises Finally,the possible problems and optimization strategies are put forward.The last part puts forward the research conclusion and the countermeasure suggestion.Through the analysis and research of the company,it is found that Hengrui medicine has taken the lead in implementing the light asset operation mode in the industry,which is customer-oriented,business integration is the key,and market-based by reducing the cost of production and manufacturing,the company's yield valve has been raised,its core competitive ability has been strengthened,its free cash flow has been guaranteed and its sales channels have been broadened For the enterprise to bring greater value-added space,and promote the good and rapid development of enterprises.Although Hengrui still maintains the leading position of domestic innovative pharmaceutical enterprises,there is still a gap between it and the stronger pharmaceutical giants in the world Enterprises need to make further efforts in improving their own R & D capabilities,strengthening their sustainable profitability,and attaching importance to personnel training.The research content of this paper is the new development of Light Asset Operation Theory and financial performance research,which is helpful to perfect the related theory research of Light Asset Operation Mode And to a certain extent,further enrich the relevant theoretical content of corporate governance.